Опыт применения молекулярного профилирования тканей Foundation One у пациента с аденокарциномой пищевода
А. А. Гурьянова, Е. В. Поддубская, Marina I Sekacheva et al. · Pharmacogenetics and Pharmacogenomics · 2021
.
Cited by 0 works. doi:10.37489/2588-0527-2020-2-32-33 Open-access PDF
Authors
References
- Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors
- Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma
- MSH3 Mismatch Repair Protein Regulates Sensitivity to Cytotoxic Drugs and a Histone Deacetylase Inhibitor in Human Colon Carcinoma Cells